|
|
||||||||
Genetics and Molecular Biology |
Department of Biochemistry and Molecular Biology, University College London, London WC1E 6BT, UK1
Author for correspondence: Peter W. Piper. Tel: +44 207 504 2212. Fax: +44 207 380 7193. e-mail: piper{at}bsm.bioc.ucl.ac.uk
During infections with a number of important eukaryotic pathogens the Hsp90 molecular chaperone of the pathogen is recognized as an immunodominant antigen by the host immune system. Yeast molecular genetics should allow study of the extent of sequence variation within conserved immunodominant epitopes on pathogen Hsp90s that is compatible with essential Hsp90 functions, as well as the processes that generate antigenic subfragments of these Hsp90s. The Hsp90 of the fungal pathogen Candida albicans was shown in this study to provide both essential and nonessential (pheromone signalling and mammalian steroid receptor activation) Hsp90 functions in Saccharomyces cerevisiae cells. Much of the C. albicans Hsp90 expressed in respiratory S. cerevisiae cells was shown to undergo a partial degradation in vivo, a degradation that closely resembles that of the native Hsp82 (one isoform of the homologous Hsp90) in S. cerevisiae. Allowing for the differences in the length of the charged linker region between the N- and C-terminal domains of C. albicans Hsp90 and S. cerevisiae Hsp82, these two proteins expressed in S. cerevisiae appear to give the same major degradation products. These Hsp90 fragments are similar to the products of incomplete Hsp90 degradation found in C. albicans cultures.
Keywords: Candida albicans, Saccharomyces cerevisiae, Hsp90, partial protein degradation, candidiasis
Abbreviations: 5-FOA, 5-fluoroorotic acid; GR, glucocorticoid receptor
This article has been cited by other articles:
![]() |
H. S. Kim, E. H. Choi, J. Khan, E. Roilides, A. Francesconi, M. Kasai, T. Sein, R. L. Schaufele, K. Sakurai, C. G. Son, et al. Expression of Genes Encoding Innate Host Defense Molecules in Normal Human Monocytes in Response to Candida albicans Infect. Immun., June 1, 2005; 73(6): 3714 - 3724. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Matthews, G. Rigg, S. Hodgetts, T. Carter, C. Chapman, C. Gregory, C. Illidge, and J. Burnie Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90 Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2208 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Burt, R. Daly, D. Hoganson, Y. Tsirulnikov, M. Essmann, and B. Larsen Isolation and Partial Characterization of Hsp90 from Candida albicans Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 86 - 93. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |